Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic Surgery

Phase 2

Completed

• Conditions: Postoperative Pain; Cancer
• Interventions: Drug: Ropivacaine

• Registration Number: NCT00210132
• Lead Sponsor: Institut Bergonié

Brief Summary

The purposes of this study are:

1. To determine the efficacy of inter pleural analgesia

2. To determine the plasmatic concentration of ropivacaine by inter pleural road

Detailed Description

Not available

Study Timeline

• Study Start: 2003-10
• Study First Submitted: 2005-09-12
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-21
• Primary Completion: 2006-06
• Study Completion: 2008-02
• Status Verified: 2015-11
• Last Update Submitted: 2015-11-25
• Last Update Posted: 2015-11-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

• Thoracotomy for oncology thoracic surgery
• Secondary or primary cancer
• American Society of Anesthesiology (ASA) class 1 or 2

Exclusion Criteria

• Ropivacaine hypersensibility
• Psychiatric disorders
• Incapacity of using visual analog scale

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Ropivacaine	Ropivacaine	-

Primary Outcome Measures

Name	Time	Method
To compare the incidence and the score of pain between the patients with ropivacaine and the patients without ropivacaine delivered by inter pleural road

Secondary Outcome Measures

Name	Time	Method
To compare the morphine consumption during 48 hours
To determine ropivacaine plasmatic concentration by inter pleural road during first 48 hours

Trial Locations

Locations (1)

Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest; 🇫🇷 Bordeaux, France